A collaborative work between Crown Bioscience and HanX Biopharma published in Nature's Scientific Reports
Corporate
Crown Bioscience, a JSR Life Sciences company, has announced that its collaborative work with HanX Biopharmaceutical Co., Ltd. (“HanX”), employing a unique and broad portfolio of preclinical modeling in support of HanX’s successful FDA Investigational New Drug (IND) application, has been published in Scientific Reports, a journal within the Nature portfolio.
For details, please see the announcement from JSR Life Sciences LLC on URL.